Dolby Laboratories (DLB) Tops Q4 EPS by 10c, Offers Q1 & FY16 Outlook
Dolby Laboratories (NYSE: DLB) reported Q4 EPS of $0.41, $0.10 better than the analyst estimate of $0.31. Revenue for the quarter came in at $229.5 million versus the consensus estimate of $235.76 million.
Dolby Laboratories sees Q1 2015 EPS of $0.43-$0.49, versus the consensus of $0.42. Dolby Laboratories sees Q1 2015 revenue of $235-245 million, versus the consensus of $248.67 million.
Fiscal Year 2016
Dolby anticipates that total revenue will range from $1 billion to $1.03 billion.
(Consensus is $1.02 billion.)
Dolby anticipates that operating expenses will be between $689 million and $699 million on a GAAP basis and between $610 million and $620 million on a non-GAAP basis.
For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.
